SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection
Tsung‐Yu Tsai(China Medical University), Shie‐Liang Hsieh(National Yang Ming Chiao Tung University), An‐Suei Yang(Genomics Research Center, Academia Sinica), Pei‐Shan Sung(Taipei Medical University), Yi-Hung Yeh(Institute of Molecular Biology, Academia Sinica), Hwai‐I Yang(Chang Gung University), James C. Paulson(University of Michigan), Ming-Ting Huang(Genomics Research Center, Academia Sinica), Mi‐Hua Tao(Institute of Biomedical Sciences, Academia Sinica), Chwan‐Deng Hsiao(Cancer Research Center), Ching-Yu Bau(Genomics Research Center, Academia Sinica), Cheng‐Yuan Peng(China Medical University), Mei‐Hung Pan(Genomics Research Center, Academia Sinica), Chung‐Yi Wu(Genomics Research Center, Academia Sinica), Shiteng Duan(Scripps Research Institute), Chih-Jen Huang(Taichung Veterans General Hospital), Wei‐Chiao Chang(Taipei Medical University Hospital), Ya-Ping Lin(Genomics Research Center, Academia Sinica), Chung-Ming Yu(Genomics Research Center, Academia Sinica)
Cited by 47
Related Papers
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
|Gastroenterology|2006|1.5k
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
Symbol Nomenclature for Graphical Representations of Glycans
|Glycobiology|2015|1.1k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653